Antimicrobial Agents and Chemotherapy · 2004 · 150 citations · 22 references
Life SciencesMicrobiologyMicrobial PathogenesisMicrobial PhysiologyMycologyFungal Cell BiologyFungal MetabolismFungal PathogenesisFungal PhysiologyPhotodynamic TherapyIn Vitro Drug Susceptibility TestingMetabolic Activity AssaysPhotosensitizing Compounds
The in vitro susceptibility of pathogenic Candida species to the photodynamic effects of the clinically approved photosensitizing agent Photofrin was examined. Internalization of Photofrin by Candida was confirmed by confocal fluorescence microscopy, and the degree of uptake was dependent on incubation concentration. Uptake of Photofrin by Candida and subsequent sensitivity to irradiation was influenced by culture conditions. Photofrin uptake was poor in C. albicans blastoconidia grown in nutrient broth. However, conversion of blastoconidia to filamentous forms by incubation in defined tissue culture medium resulted in substantial Photofrin uptake. Under conditions where Photofrin was effectively taken up by Candida, irradiated organisms were damaged in a drug dose- and light-dependent manner. Uptake of Photofrin was not inhibited by azide, indicating that the mechanism of uptake was not dependent on energy provided via electron transport. Fungal damage induced by Photofrin-mediated photodynamic therapy (PDT) was determined by evaluation of metabolic activity after irradiation. A strain of C. glabrata took up Photofrin poorly and was resistant to killing after irradiation. In contrast, two different strains of C. albicans displayed comparable levels of sensitivity to PDT. Furthermore, a reference strain of C. krusei that is relatively resistant to fluconazole compared to C. albicans was equally sensitive to C. albicans at Photofrin concentrations of >/=3 microg/ml. The results indicate that photodynamic therapy may be a useful adjunct or alternative to current anti-Candida therapeutic modalities, particularly for superficial infections on surfaces amenable to illumination.
22
Killing of cutaneous microbial species by photodynamic therapy
B. Zeina, John Greenman, Wendy M. Purcell et al. · British Journal of Dermatology · 2001 · 260 citations
Elizabeth M. Johnson, David W. Warnock, Jane Luker et al. · Journal of Antimicrobial Chemotherapy · 1995 · 256 citations
Tova Meshulam, Stuart M. Levitz, Laurent Christin et al. · The Journal of Infectious Diseases · 1995 · 190 citations